MondayFeb 08, 2021 12:36 pm

2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp. is a life sciences technology accelerator involved in the development of new pharmaceuticals, diagnostic products and psychedelic investments XPhyto is preparing a series of clinical pilot studies for four drug candidates this year that could help in treating Parkinson’s disease, epilepsy, anorexia and other neurological conditions The company has developed a rapid and highly portable PCR test kit it expects to commercialize this year to provide point-of-care diagnostics, designed for satellite labs to quickly screen for the COVID-19 virus Wholly owned subsidiary Vektor, a German drug maker and researcher, plans to build a new commercial drug manufacturing…

Continue Reading

ThursdayFeb 04, 2021 12:09 pm

CBD Market Steadiness Buoys HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) Hopes as TSX Launch Completed

Health and wellness company HempFusion Wellness, Inc. launched its IPO Jan. 6 with the ticker CBD.U, and also trades in the US under the symbol CBDHF The company distributes its brands HempFusion, Probulin Probiotics, Biome Research and HF Labs to 4,000 retailers in every state as well as select international locales, and is strategically planning for expansion Despite the economic battering some industries have experienced as a result of the global pandemic, hemp and CBD continue to see consumer use trends holding stable with forecasts for new market growth in coming years HempFusion is focused on regulatory compliance with industry…

Continue Reading

WednesdayFeb 03, 2021 3:38 pm

Grapefruit USA Inc. (GPFT) Is ‘One to Watch’

Grapefruit USA Inc. holds licensing for manufacturing and distribution in California, issued in 2018; the company is positioned as a premier distributor and manufacturer in the state, with a focus on procuring, manufacturing and distributing the highest-quality materials With cannabis legalization gaining momentum worldwide, Grapefruit is currently uniquely situated to disrupt the market through its novel and proprietary products and services The global cannabis market is expected to grow to $97.35 billion by 2026, expanding at a CAGR of 32.92% The company provides a wealth of cannabis flower and cannabis products to licensed businesses, along with various services including distribution,…

Continue Reading

WednesdayFeb 03, 2021 2:59 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Updates Investors Following Completion of Special Warrants Private Placement

Pure Extracts recently updated investors on successful completion of second tranche of its special warrants private placement In aggregate, Company will raise gross proceeds of $8.5 million through both tranches of private placement Pure Extracts will employ net proceeds from private placement towards capacity expansion for Company’s extraction business, and for general working capital purposes Company previously revealed that it was conducting study looking into formulation, manufacturing of psilocybin-based active treatments Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, and functional mushroom sectors, has recently updated investors following the successful…

Continue Reading

WednesdayFeb 03, 2021 2:22 pm

PacRoots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Set to Thrive as Peers Face Pain of Excess Supply

PacRoots Cannabis recently updated investors following its first successful hemp harvest, which resulted in 105,000 lbs. of biomass of higher-than-expected quality Canadian cannabis market is currently awash in oversupply, with some estimates placing inventory stockpile at close to 3 years’ worth of demand Industry participants have pointed at low-quality grades as prime cause for the oversupply PacRoots has taken strides to improve quality of its plants, most notably through collaboration with Phenome One Corp PacRoots processes, sells entirety of recent harvest to the Speakeasy Cannabis Club PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), an up-and-coming cannabis company based out of Canada,…

Continue Reading

WednesdayFeb 03, 2021 1:54 pm

RYAH Group Inc. Partners with THC Lab to Launch Dose-Measuring Inhaler and Data Analytics Platform in Italy, Netherlands

Agreement between RYAH, THC Lab outlines parameters for launch of RYAH’s IoT dose-measuring Smart-Inhaler Aim of agreement is to reach hundreds of pharmacies, establish RYAH as the market standard for vaporizing The two companies also planning to work together on controlled research, bioavailability testing projects RYAH Group, a leading digital health care analytics and technology company, has entered into a research-and-distribution arrangement THC Lab, which specializes in providing products and services to compounding pharmacies in Italy and other European countries in the specific field of medical cannabis (https://cnw.fm/9S8To). The agreement outlines the parameters for the launch of RYAH’s IoT dose-measuring…

Continue Reading

TuesdayFeb 02, 2021 3:36 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Is ‘One to Watch’

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities The company has research and development operations in North America and Europe and an operational focus in Germany XPhyto’s operations are concentrated into three core divisions: infectious disease diagnostics, clinical development of transdermal and sublingual drug formulations, and psychedelic medicine The company’s lead diagnostic product is an accurate, rapid and highly portable PCR diagnostic test system being evaluated in Europe for the detection of COVID-19 XPhyto’s German subsidiary, Vektor Pharma TF GmbH, is advancing four therapeutic programs targeting neurological indications;…

Continue Reading

TuesdayFeb 02, 2021 2:57 pm

CannAssist International Corp. (CNSC) Proprietary Tech Is Core of CBD Products with Better Absorption

Absorption vital component of product effectiveness CNSC's proprietary CiBiDinol technology is cannabidiol made water compatible Xceptol products offer CBD in format more in line with body's natural bioactivity CannAssist International (OTCQB: CNSC) is a biotechnological pharmaceutical and wellness company marketing its exclusive Xceptol consumer brand. The company is the owner of Xceptor Labs, which uses proprietary technology to create Xceptol CBD products. The company complex has better absorption than currently marketed oil-based products — a key advantage when assessing products' effectiveness. Drug absorption, or the way a drug is absorbed into the bloodstream, is a vital component in the effectiveness…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722